Refresh

Kilitch Drugs(I) Ltd. - Research Center

524500 KILITCH Group (B) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

117.78 105.16 70.02 60.77 96.42
Expenses

Material consumed

60.87 62.36 39.88 36.43 53.65

Manufacturing expenses

2.06 2.00 1.57 1.62 1.41

Personnel expenses

7.47 6.15 5.22 5.65 5.23

Selling expenses

0.09 0.02 0.02 0.06 1.08

Adminstrative expenses

30.13 23.63 18.12 15.62 18.45

Expenses capitalised

- - - - -

Cost of sales

100.61 94.16 64.81 59.39 79.83

Operating profit

17.17 11.00 5.21 1.38 16.59

Other recurring income

4.60 4.56 4.19 5.71 4.52

Adjusted PBDIT

21.77 15.56 9.40 7.09 21.11

Financial expenses

0.99 0.66 0.75 0.72 0.38

Depreciation

1.34 0.96 1.14 1.15 1.20

Other write offs

- - - - -

Adjusted PBT

19.45 13.93 7.51 5.22 19.52

Tax charges

3.73 3.40 1.35 0.77 4.76

Adjusted PAT

15.72 10.53 6.16 4.46 14.77

Non recurring items

- - - - -

Other non cash adjustments

- - - - -

Reported net profit

15.72 10.53 6.16 4.46 14.77

Earnigs before appropriation

113.96 98.24 87.71 82.49 78.96

Equity dividend

- - - 0.93 0.93

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

113.96 98.24 87.71 81.56 78.03
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com